Free Trial

Swiss National Bank Has $130.60 Million Stake in Exelon Corporation (NASDAQ:EXC)

Exelon logo with Utilities background

Key Points

  • The Swiss National Bank has increased its stake in Exelon Corporation by 0.3%, now owning approximately 2.83 million shares valued at $130.6 million.
  • Exelon recently reported earnings per share (EPS) of $0.39 for the last quarter, exceeding analyst expectations by $0.02, although revenue slightly missed forecasts at $5.43 billion.
  • The company has declared a quarterly dividend of $0.40 per share, equating to an annualized yield of 3.5%, with the dividend payout ratio currently at 60.84%.
  • Want stock alerts on Exelon? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Swiss National Bank lifted its holdings in shares of Exelon Corporation (NASDAQ:EXC - Free Report) by 0.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,834,155 shares of the company's stock after purchasing an additional 7,800 shares during the quarter. Swiss National Bank owned approximately 0.28% of Exelon worth $130,598,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of EXC. Price T Rowe Associates Inc. MD grew its stake in Exelon by 37.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 27,618,055 shares of the company's stock valued at $1,039,545,000 after buying an additional 7,483,873 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Exelon by 43.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 12,846,030 shares of the company's stock valued at $483,525,000 after buying an additional 3,878,687 shares during the last quarter. Royal Bank of Canada grew its stake in Exelon by 125.6% in the 4th quarter. Royal Bank of Canada now owns 3,838,729 shares of the company's stock valued at $144,489,000 after buying an additional 2,137,439 shares during the last quarter. Deutsche Bank AG grew its stake in Exelon by 11.6% in the 1st quarter. Deutsche Bank AG now owns 19,077,520 shares of the company's stock valued at $879,092,000 after buying an additional 1,988,212 shares during the last quarter. Finally, Northern Trust Corp grew its stake in Exelon by 16.4% in the 4th quarter. Northern Trust Corp now owns 11,212,263 shares of the company's stock valued at $422,030,000 after buying an additional 1,577,317 shares during the last quarter. Institutional investors and hedge funds own 80.92% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. Wells Fargo & Company increased their price target on shares of Exelon from $46.00 to $50.00 and gave the company an "equal weight" rating in a report on Friday, May 2nd. UBS Group reissued a "neutral" rating and issued a $48.00 price target (up from $47.00) on shares of Exelon in a report on Friday, July 11th. Morgan Stanley reduced their price target on shares of Exelon from $49.00 to $48.00 and set an "equal weight" rating for the company in a report on Thursday, May 22nd. BMO Capital Markets increased their price target on shares of Exelon from $46.00 to $50.00 and gave the company an "outperform" rating in a report on Monday, April 28th. Finally, Guggenheim increased their price target on shares of Exelon from $47.00 to $50.00 and gave the company a "buy" rating in a report on Friday, May 2nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $47.20.

Check Out Our Latest Stock Report on EXC

Exelon Price Performance

Shares of NASDAQ EXC traded down $0.61 during trading on Monday, reaching $44.71. The company had a trading volume of 4,396,355 shares, compared to its average volume of 6,018,795. Exelon Corporation has a 52 week low of $35.94 and a 52 week high of $48.11. The stock has a market cap of $45.16 billion, a PE ratio of 17.04, a PEG ratio of 2.66 and a beta of 0.38. The company has a debt-to-equity ratio of 1.66, a quick ratio of 0.85 and a current ratio of 0.95. The business's 50 day moving average price is $43.44 and its 200-day moving average price is $43.83.

Exelon (NASDAQ:EXC - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The company reported $0.39 earnings per share for the quarter, topping analysts' consensus estimates of $0.37 by $0.02. The business had revenue of $5.43 billion during the quarter, compared to the consensus estimate of $5.47 billion. Exelon had a net margin of 11.16% and a return on equity of 9.85%. Exelon's revenue for the quarter was up 1.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.47 earnings per share. Analysts expect that Exelon Corporation will post 2.64 earnings per share for the current year.

Exelon Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Monday, August 11th will be issued a dividend of $0.40 per share. The ex-dividend date is Monday, August 11th. This represents a $1.60 dividend on an annualized basis and a yield of 3.6%. Exelon's payout ratio is currently 60.84%.

About Exelon

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Featured Articles

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Should You Invest $1,000 in Exelon Right Now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines